Cardiac troponin I elevation and overall survival among cancer patients receiving investigational compounds during phase I trials

Postel-Vinay, 2014, Eur J Cancer, 50, 2040, 10.1016/j.ejca.2014.04.031 Johnson, 2015, Evaluation, prevention and management of cancer therapy-induced cardiotoxicity: a contemporary approach for clinicians, Curr Opin Cardiol, 10.1097/HCO.0000000000000145 Ky, 2014, Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab, J Am Coll Cardiol, 63, 809, 10.1016/j.jacc.2013.10.061 Thygesen, 2012, Third universal definition of myocardial infarction, Circulation, 126, 2020, 10.1161/CIR.0b013e31826e1058 Plana, 2014, Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr, 27, 911, 10.1016/j.echo.2014.07.012 Cardinale, 2010, Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation, J Clin Oncol, 28, 3910, 10.1200/JCO.2009.27.3615 Ederhy, 2012, Frequency and management of troponin I elevation in patients treated with molecular targeted therapies in phase I trials, Invest New Drugs, 30, 611, 10.1007/s10637-010-9546-8 Wang, 2015, Broad targeting of angiogenesis for cancer prevention and therapy, Semin Cancer Biol, 35, S224, 10.1016/j.semcancer.2015.01.001 Schmidinger, 2008, Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma, J Clin Oncol, 26, 5204, 10.1200/JCO.2007.15.6331 Chu, 2007, Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib, Lancet, 370, 2011, 10.1016/S0140-6736(07)61865-0 Ploquin, 2012, Life-expectancy of patients enrolled in phase 1 clinical trials: a systematic review of published prognostic models, Crit Rev Oncol Hematol, 83, 242, 10.1016/j.critrevonc.2011.11.008 Olmos, 2012, Patient selection for oncology phase I trials: a multi-institutional study of prognostic factors, J Clin Oncol, 30, 996, 10.1200/JCO.2010.34.5074 Pavo, 2015, Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality, Heart, 101, 1874, 10.1136/heartjnl-2015-307848 Rhea, 2015, Incremental prognostic value of echocardiographic strain and its association with mortality in cancer patients, J Am Soc Echocardiogr, 28, 667, 10.1016/j.echo.2015.02.006